Agonist-directed Interactions with Specific β-Arrestins Determine μ-Opioid Receptor Trafficking, Ubiquitination, and Dephosphorylation
Agonist-directed Interactions with Specific β-Arrestins Determine μ-Opioid Receptor Trafficking, Ubiquitination, and Dephosphorylation
复制标题
DOI:
10.1074/jbc.m111.248310
复制
发表时间:
2011-09-09
影响因子:
4.8
通讯作者:
Bohn, Laura M.
中科院分区:
文献类型:
--
作者:
Groer, Chad E.;Schmid, Cullen L.;Bohn, Laura M.
Morphine and other opiates mediate their effects through activation of the mu-opioid receptor (MOR), and regulation of the MOR has been shown to critically affect receptor responsiveness. Activation of the MOR results in receptor phosphorylation, beta-arrestin recruitment, and internalization. This classical regulatory process can differ, depending on the ligand occupying the receptor. There are two forms of beta-arrestin, beta-arrestin1 and beta-arrestin2 (also known as arrestin2 and arrestin3, respectively); however, most studies have focused on the consequences of recruiting beta-arrestin2 specifically. In this study, we examine the different contributions of beta-arrestin1- and beta-arrestin2-mediated regulation of the MOR by comparing MOR agonists in cells that lack expression of individual or both beta-arrestins. Here we show that morphine only recruits beta-arrestin2, whereas the MOR-selective enkephalin [D-Ala(2), N-Me-Phe(4), Gly(5)-ol] enkephalin (DAMGO), recruits either beta-arrestin. We show that beta-arrestins are required for receptor internalization and that only beta-arrestin2 can rescue morphine-induced MOR internalization, whereas either beta-arrestin can rescue DAMGO-induced MOR internalization. DAMGO activation of the receptor promotes MOR ubiquitination over time. Interestingly, beta-arrestin1 proves to be critical for MOR ubiquitination as modification does not occur in the absence of beta-arrestin1 nor when morphine occupies the receptor. Moreover, the selective interactions between the MOR and beta-arrestin1 facilitate receptor dephosphorylation, which may play a role in the resensitization of the MOR and thereby contribute to overall development of opioid tolerance.